Leukemia Statistics

Statistics on Leukemia Survival Rates

Leukemia survival rates can be calculated by different methods for different purposes. The survival rates presented here are based on the relative survival rate. The relative survival rate measures the survival of the cancer patients in comparison to the general population to estimate the effect of the disease. The overall five-year relative survival rate for 1995-2001 was 47.6 percent.
 
The five-year relative survival rates by race and sex were:
 
  • 49.6 percent for Caucasian men
  • 48.4 percent for Caucasian women
  • 39.2 percent for African American men
  • 36.9 percent for African American women.
 

Leukemia Statistics: Lifetime Risk

Based on rates from 2000-2002, 1.27 percent of men and women (or 1 in 79 men and women) born today will be diagnosed with leukemia at some point during their lifetime. These statistics are referred to as the lifetime risk of developing cancer. Sometimes, it is more useful to look at the probability of developing leukemia between two age groups. For example, 0.48 percent of men will develop the disease between their 50th and 70th birthdays, compared to 0.28 percent of women.
 

Statistics on Leukemia Prevalence Rate

On January 1, 2002, in the United States there were approximately 189,865 men and women alive who had a history of leukemia -- 106,434 men and 83,431 women. This prevalence rate includes any person alive on January 1, 2002, who had been diagnosed with the disease at any point prior to January 1, 2002, any person with active disease, and those who had been cured of their disease.
7 Natural Ways to Reduce Your Cancer Pain

Leukemia Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.